Thursday, May 15, 2008

Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference

Presentation to be Webcast Live at 2:00 p.m. ET Thursday, May 22

WESTFORD, Mass., May 15 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(Nasdaq: CYNO), a leading developer and manufacturer of a broad array of
light-based aesthetic treatment systems, today announced that its senior
management will present at the 2008 Citi Investment Research Global Health
Care Conference, taking place at the Hilton New York.

Cynosure's presentation will be webcast live over the Internet
beginning at 2:00 p.m. (ET) Thursday, May 22, 2008. President and Chief
Executive Officer Michael Davin and Chief Financial Officer Timothy Baker
plan to discuss Cynosure's business outlook, growth strategy and recent
financial results. To access the live or archived webcast, visit the
"Investor Relations" portion of Cynosure's website at http://www.cynosure.com.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that
are used by physicians and other practitioners to perform non-invasive and
minimally invasive procedures to remove hair, treat vascular lesions,
rejuvenate skin through the treatment of shallow vascular and pigmented
lesions, laser lipolysis and temporarily reduce the appearance of
cellulite. Cynosure's products include a broad range of laser and other
light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and
diode lasers, as well as intense pulsed light. Cynosure was founded in
1991. For corporate or product information, contact Cynosure at
800-886-2966, or visit http://www.cynosure.com.



Contact:

Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com




See Also

Via: Healthcare

0 коментарі: